What is Oruka Therapeutics, Inc.'s short- term investments?

Oruka Therapeutics, Inc. (ORKA) reported short- term investments of $339.31M in Q1 2026.

How has Oruka Therapeutics, Inc.'s short- term investments changed year-over-year?

Oruka Therapeutics, Inc.'s short- term investments increased by 27.8% year-over-year, from $265.52M to $339.31M.

Oruka Therapeutics, Inc. ORKA Short- term Investments

Short- term Investments at other companies

Johnson & JohnsonJNJ

——

Protagonist TherapeuticsPTGX

——

Erasca, Inc.ERAS

——

ImmunityBio, Inc.IBRX

——

Celldex TherapeuticsCLDX

——

Apogee Therapeutics, Inc.APGE

——

Other financials

Income statement

See full

Revenue-—

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$5.03B+533%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s short- term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s short- term investments?: Oruka Therapeutics, Inc. (ORKA) reported short- term investments of $339.31M in Q1 2026.
How has Oruka Therapeutics, Inc.'s short- term investments changed year-over-year?: Oruka Therapeutics, Inc.'s short- term investments increased by 27.8% year-over-year, from $265.52M to $339.31M.